Atrys Health SA (A2T) Ratios
Atrys Health SA Ratios
DE:A2T's free cash flow for Q2 2026 was $-1.23M. For the 2026 fiscal year, DE:A2T's free cash flow was decreased by $-1.16M and operating cash flow was $-63.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.81 | 0.89 | 0.97 | 1.01 | 1.44 |
| Quick Ratio | 0.80 | 0.88 | 0.96 | 1.00 | 1.43 |
| Cash Ratio | 0.04 | 0.20 | 0.40 | 0.34 | 0.49 |
| Solvency Ratio | -0.21 | -0.01 | -0.05 | 0.01 | -0.01 |
| Operating Cash Flow Ratio | -0.01 | 0.03 | 0.05 | -0.15 | 0.07 |
| Short-Term Operating Cash Flow Coverage | -0.01 | 0.21 | 0.10 | -0.66 | 0.39 |
| Net Current Asset Value | $ -108.13M | $ -241.77M | $ -238.25M | $ -265.84M | $ -188.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.28 | 0.40 | 0.34 | 0.27 |
| Debt-to-Equity Ratio | 1.70 | 0.66 | 0.88 | 0.71 | 0.57 |
| Debt-to-Capital Ratio | 0.63 | 0.40 | 0.47 | 0.42 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.37 | 0.36 | 0.35 | 0.28 |
| Financial Leverage Ratio | 3.25 | 2.31 | 2.17 | 2.09 | 2.06 |
| Debt Service Coverage Ratio | -0.04 | 0.55 | 0.38 | 0.38 | 0.33 |
| Interest Coverage Ratio | -0.47 | -0.45 | -0.05 | -0.48 | -1.36 |
| Debt to Market Cap | 1.04 | 0.65 | 0.79 | 0.48 | 0.21 |
| Interest Debt Per Share | 3.65 | 2.51 | 3.78 | 3.75 | 3.10 |
| Net Debt to EBITDA | -24.57 | 7.64 | 6.65 | 12.44 | 20.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.51% | 68.34% | 70.33% | 15.28% | 83.37% |
| EBIT Margin | -26.37% | -4.69% | 1.11% | -5.90% | -12.32% |
| EBITDA Margin | -7.07% | 8.96% | 15.83% | 10.50% | 4.85% |
| Operating Profit Margin | -6.40% | -4.96% | -0.78% | -4.40% | -12.41% |
| Pretax Profit Margin | -39.86% | -15.73% | -16.72% | -15.08% | -20.56% |
| Net Profit Margin | -71.13% | -14.94% | -22.62% | -14.62% | -19.17% |
| Continuous Operations Profit Margin | -39.45% | -14.97% | -15.26% | -16.39% | -19.17% |
| Net Income Per EBT | 178.46% | 94.93% | 135.30% | 96.93% | 93.23% |
| EBT Per EBIT | 622.79% | 317.22% | 2129.96% | 342.41% | 165.73% |
| Return on Assets (ROA) | -20.30% | -5.44% | -7.25% | -3.28% | -4.10% |
| Return on Equity (ROE) | -66.05% | -12.55% | -15.73% | -6.86% | -8.47% |
| Return on Capital Employed (ROCE) | -4.43% | -2.18% | -0.30% | -1.15% | -3.04% |
| Return on Invested Capital (ROIC) | -2.09% | -1.99% | -0.24% | -1.10% | -2.73% |
| Return on Tangible Assets | -35.07% | -19.85% | -25.54% | -12.42% | -12.98% |
| Earnings Yield | -45.08% | -12.46% | -16.35% | -5.47% | -4.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.79 | 4.03 | 4.52 | 2.86 | 2.23 |
| Payables Turnover | 3.57 | 2.66 | 3.12 | 2.07 | 1.25 |
| Inventory Turnover | 35.63 | 42.90 | 35.66 | 26.78 | 25.37 |
| Fixed Asset Turnover | 3.22 | 3.66 | 3.23 | 2.28 | 1.94 |
| Asset Turnover | 0.29 | 0.36 | 0.32 | 0.22 | 0.21 |
| Working Capital Turnover Ratio | -4.20 | -31.80 | -275.56 | 9.62 | 5.10 |
| Cash Conversion Cycle | -15.68 | -38.29 | -25.76 | -35.18 | -112.84 |
| Days of Sales Outstanding | 76.25 | 90.62 | 80.81 | 127.46 | 163.76 |
| Days of Inventory Outstanding | 10.25 | 8.51 | 10.24 | 13.63 | 14.39 |
| Days of Payables Outstanding | 102.18 | 137.42 | 116.80 | 176.27 | 290.99 |
| Operating Cycle | 86.49 | 99.13 | 91.04 | 141.09 | 178.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | 0.04 | 0.08 | -0.23 | 0.09 |
| Free Cash Flow Per Share | -0.19 | -0.13 | -0.01 | -0.45 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -0.12 | 0.23 | 0.91 | -1.02 | 0.55 |
| Capital Expenditure Coverage Ratio | -0.12 | 0.23 | 0.91 | -1.02 | 0.55 |
| Operating Cash Flow Coverage Ratio | -0.01 | 0.02 | 0.02 | -0.06 | 0.03 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.01 | 0.03 | -0.10 | 0.04 |
| Free Cash Flow Yield | -6.33% | -3.98% | -0.20% | -7.24% | -0.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.22 | -8.02 | -6.12 | -18.27 | -23.42 |
| Price-to-Sales (P/S) Ratio | 1.58 | 1.20 | 1.38 | 2.67 | 4.49 |
| Price-to-Book (P/B) Ratio | 1.47 | 1.01 | 0.96 | 1.25 | 1.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.81 | -25.14 | -509.80 | -13.82 | -140.26 |
| Price-to-Operating Cash Flow Ratio | -142.71 | 85.07 | 48.93 | -27.40 | 115.73 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.27 | -0.08 | 0.87 | -0.20 |
| Enterprise Value Multiple | -46.90 | 21.01 | 15.39 | 37.88 | 112.88 |
| Enterprise Value | 467.29M | 400.71M | 491.03M | 629.79M | 663.05M |
| EV to EBITDA | -46.90 | 21.01 | 15.39 | 37.88 | 112.88 |
| EV to Sales | 3.31 | 1.88 | 2.44 | 3.98 | 5.48 |
| EV to Free Cash Flow | -33.20 | -39.51 | -897.68 | -20.58 | -171.20 |
| EV to Operating Cash Flow | -299.74 | 133.70 | 86.16 | -40.81 | 141.26 |
| Tangible Book Value Per Share | -0.74 | -2.26 | -2.11 | -2.66 | -2.11 |
| Shareholders’ Equity Per Share | 2.00 | 3.35 | 3.81 | 4.95 | 5.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.05 | 0.09 | -0.09 | 0.07 |
| Revenue Per Share | 1.86 | 2.81 | 2.65 | 2.32 | 2.26 |
| Net Income Per Share | -1.32 | -0.42 | -0.60 | -0.34 | -0.43 |
| Tax Burden | 1.78 | 0.95 | 1.35 | 0.97 | 0.93 |
| Interest Burden | 1.51 | 3.36 | -15.04 | 2.56 | 1.67 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 |
| SG&A to Revenue | 0.03 | 0.01 | 0.03 | 0.11 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.03 | -0.09 | -0.17 | 0.63 | -0.20 |
Currency in EUR